Cargando…

Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study

Detalles Bibliográficos
Autores principales: Moyle, G, Orkin, C, Fisher, M, Anderson, J, Dhar, J, Wang, MH, Ewan, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113087/
http://dx.doi.org/10.1186/1758-2652-13-S4-P80
_version_ 1782205884952215552
author Moyle, G
Orkin, C
Fisher, M
Anderson, J
Dhar, J
Wang, MH
Ewan, J
author_facet Moyle, G
Orkin, C
Fisher, M
Anderson, J
Dhar, J
Wang, MH
Ewan, J
author_sort Moyle, G
collection PubMed
description
format Online
Article
Text
id pubmed-3113087
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130872011-06-13 Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study Moyle, G Orkin, C Fisher, M Anderson, J Dhar, J Wang, MH Ewan, J J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113087/ http://dx.doi.org/10.1186/1758-2652-13-S4-P80 Text en Copyright ©2010 Moyle et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Moyle, G
Orkin, C
Fisher, M
Anderson, J
Dhar, J
Wang, MH
Ewan, J
Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
title Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
title_full Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
title_fullStr Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
title_full_unstemmed Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
title_short Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
title_sort switching from kivexa + efavirenz to atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113087/
http://dx.doi.org/10.1186/1758-2652-13-S4-P80
work_keys_str_mv AT moyleg switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy
AT orkinc switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy
AT fisherm switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy
AT andersonj switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy
AT dharj switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy
AT wangmh switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy
AT ewanj switchingfromkivexaefavirenztoatriplareducestotalcholesterolinhypercholesterolemicsubjectsfinalresultsofa24weekrandomizedstudy